FDA-Approved Trial

FemPulse is currently recruiting for a 12-month FDA-approved clinical trial for women suffering from overactive bladder (OAB) with symptoms such as urgency, frequency, or leakage.  This follows four previous successful trials of the vaginally-inserted FemPulse Ring, and serves as the pivotal trial for potential FDA clearance.

New Study For overactive bladder (OAB) - Now Enrolling

Enter Trial Site

There are clinical trial sites in the following locations:

California:

Cedars Sinai
Los Angeles, CA

Stanford University
Palo Alto, CA

UC Irvine
Irvine, CA

UCLA
Los Angels, CA

UC San Diego
San Diego, CA

Forida:

Holy Cross Hospital
Ft. Lauderdale, FL

Illinois:

Comprehensive Urology
Lake Barrington, IL

Kentucky:

University of Louisville
Louisville, KY

Maryland:

Chesapeake Urology
Baltimore, MD

Minnesota:

Minnesota Urology
St. Paul, MN

Nebraska:

Adult Pediatric Urology
Omaha, NE

North Carolina:

Atrium Health
Charlotte, NC

South Carolina:

Southern Urogynecology
Columbia, SC

South Dakota:

Sanford Health
Sioux Falls, SD

Virginia:

Inova Urogynecology
Reston, VA

New Study For overactive bladder (OAB) - Now Enrolling

Enter Trial Site